Nevada · Senate Bill 177 · 82nd (2023) Session

Imposes requirements governing Medicaid coverage of certain antipsychotic or anticonvulsant drugs. (BDR 38-82)

  1. Introduced Feb 20, 2023
  2. In committee Feb 20, 2023
  3. Passed the Senate Apr 17, 2023
  4. Passed the Assembly May 23, 2023
  5. To the governor May 26, 2023
  6. Became law May 31, 2023

What it does

The legislature's own summary of the bill, or its official long title.

Existing law requires the Department of Health and Human Services to develop a list of preferred prescription drugs to be used for the Medicaid program. (NRS 422.4025) The policies of the Department currently provide for the coverage of any typical or atypical antipsychotic medication or anticonvulsant medication that is not on the list of preferred prescription drugs upon the demonstrated therapeutic failure of one…

Read the full title (222 words)

Existing law requires the Department of Health and Human Services to develop a list of preferred prescription drugs to be used for the Medicaid program. (NRS 422.4025) The policies of the Department currently provide for the coverage of any typical or atypical antipsychotic medication or anticonvulsant medication that is not on the list of preferred prescription drugs upon the demonstrated therapeutic failure of one drug on that list to adequately treat the condition of a recipient of Medicaid. (Medicaid Services Manual 1203.1(B)(1)(h)) Section 1 of this bill codifies this requirement in law, and sections 2 and 4 of this bill clarify that the requirement applies to health maintenance organizations and other managed care organizations providing coverage to recipients of Medicaid. Section 3 of this bill authorizes the Commissioner of Insurance to suspend or revoke the certificate of authority of a health maintenance organization that fails to comply with the requirement of section 2 to cover any typical or atypical antipsychotic medication or anticonvulsant medication that is not on the list of preferred prescription drugs upon the demonstrated therapeutic failure of one drug on that list to adequately treat the condition of a recipient of Medicaid. The Commissioner would also be authorized to take such action against other managed care organizations who fail to comply with the requirements of section 4. (NRS 680A.200)

Every action

30 steps, oldest first, as the legislature records them.

Show the 22 earlier steps
  1. SenateRead first time.
  2. CommitteeReferred to Committee on Health and Human Services. · Senate Health and Human Services
  3. SenateTo printer.
  4. SenateFrom printer.
  5. SenateTo committee.
  6. CommitteeFrom committee: Do pass. · Senate Health and Human Services
  7. SenateRead second time.
  8. SenateTaken from General File.
  9. SenatePlaced on General File for next legislative day.
  10. SenateTaken from General File.
  11. SenatePlaced on General File for next legislative day.
  12. SenateRead third time.
  13. SenatePassed. Title approved. (Yeas: 19, Nays: 1, Excused: 1.)
  14. SenateTo Assembly.
  15. AssemblyIn Assembly.
  16. AssemblyRead first time.
  17. CommitteeReferred to Committee on Health and Human Services. · Assembly Health and Human Services
  18. AssemblyTo committee.
  19. CommitteeFrom committee: Do pass. · Assembly Health and Human Services
  20. AssemblyRead second time.
  21. AssemblyTaken from General File.
  22. AssemblyPlaced on General File for next legislative day.
  1. AssemblyRead third time.
  2. AssemblyPassed. Title approved. (Yeas: 42, Nays: None.)
  3. AssemblyTo Senate.
  4. SenateIn Senate.
  5. SenateTo enrollment.
  6. SenateEnrolled and delivered to Governor.
  7. GovernorApproved by the Governor.
  8. Secretary of StateChapter 106.

Roll calls

2 recorded votes: 2 on the floor, 0 in committee. Each shows how every member voted.

Sponsors

The 2 members who introduced it, joined by 8 cosponsors: 8 Democrats.

All 8 cosponsors

From Nevada's official records (leg.state.nv.us), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.